120 related articles for article (PubMed ID: 36007391)
1. LipoxinA
Hao H; Xie F; Xu F; Wang Q; Wu Y; Zhang D
Int Immunopharmacol; 2022 Oct; 111():109170. PubMed ID: 36007391
[TBL] [Abstract][Full Text] [Related]
2. BML-111 attenuates high glucose-induced inflammation, oxidative stress and reduces extracellular matrix accumulation via targeting Nrf2 in rat glomerular mesangial cells.
Wu X; Pan C; Chen R; Zhang S; Zhai Y; Guo H
Int Immunopharmacol; 2020 Feb; 79():106108. PubMed ID: 31881376
[TBL] [Abstract][Full Text] [Related]
3. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
[TBL] [Abstract][Full Text] [Related]
4. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
Zhang Q; Hu Y; Hu JE; Zhang M
Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
[TBL] [Abstract][Full Text] [Related]
5. Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK/Nrf2 pathway.
Tian H; Zheng X; Wang H
Int Urol Nephrol; 2023 Feb; 55(2):423-436. PubMed ID: 35960477
[TBL] [Abstract][Full Text] [Related]
6. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation.
Feng J; Xie L; Yu X; Liu C; Dong H; Lu W; Kong R
Biochem Biophys Res Commun; 2021 Mar; 544():22-30. PubMed ID: 33516878
[TBL] [Abstract][Full Text] [Related]
7. The LipoxinA4 receptor agonist BML-111 ameliorates intestinal disruption following acute pancreatitis through the Nrf2-regulated antioxidant pathway.
Shi Z; Wang Y; Ye W; Lin Z; Deng T; Zhang T; Zhao J; Tong Y; Shan Y; Chen G
Free Radic Biol Med; 2021 Feb; 163():379-391. PubMed ID: 33383086
[TBL] [Abstract][Full Text] [Related]
8. Lipoxin A
Xu F; Zhang J; Zhou X; Hao H
Exp Cell Res; 2022 Mar; 412(1):113025. PubMed ID: 35026282
[TBL] [Abstract][Full Text] [Related]
9. Decreasing REDD1 expression protects against high glucose-induced apoptosis, oxidative stress and inflammatory injury in podocytes through regulation of the AKT/GSK-3β/Nrf2 pathway.
Wang X; Yang J; Wang W; Li Y; Yang Y
Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):527-538. PubMed ID: 36883011
[TBL] [Abstract][Full Text] [Related]
10. BML-111 accelerates the resolution of inflammation by modulating the Nrf2/HO-1 and NF-κB pathways in rats with ventilator-induced lung injury.
Xu J; Li HB; Chen L; Wang YX; Lu S; Li SN; Cui SN; Xiao HR; Qin L; Hu H; Yao S; Shang Y
Int Immunopharmacol; 2019 Apr; 69():289-298. PubMed ID: 30753968
[TBL] [Abstract][Full Text] [Related]
11. TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway.
Chen Z; Tian L; Wang L; Ma X; Lei F; Chen X; Fu R
Inflammation; 2022 Jun; 45(3):992-1006. PubMed ID: 34783942
[TBL] [Abstract][Full Text] [Related]
12. Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3β.
Shen Y; Chen S; Zhao Y
Biochem Biophys Res Commun; 2019 Sep; 516(4):1137-1144. PubMed ID: 31284950
[TBL] [Abstract][Full Text] [Related]
13. TDAG51-Deficiency Podocytes are Protected from High-Glucose-Induced Damage Through Nrf2 Activation via the AKT-GSK-3β Pathway.
Liu C; Li Y; Wang X
Inflammation; 2022 Aug; 45(4):1520-1533. PubMed ID: 35175494
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of USP15 ameliorates high-glucose-induced oxidative stress and inflammatory injury in podocytes through regulation of the Keap1/Nrf2 signaling.
Xu E; Yin C; Yi X; Liu Y
Environ Toxicol; 2022 Apr; 37(4):765-775. PubMed ID: 34931430
[TBL] [Abstract][Full Text] [Related]
15. The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation.
Martinez RM; Fattori V; Saito P; Pinto IC; Rodrigues CCA; Melo CPB; Bussmann AJC; Staurengo-Ferrari L; Bezerra JR; Vignoli JA; Baracat MM; Georgetti SR; Verri WA; Casagrande R
Molecules; 2020 Jun; 25(12):. PubMed ID: 32604968
[TBL] [Abstract][Full Text] [Related]
16. A synthetic analog of lipoxin A4 partially alleviates dexamethasone-induced fetal growth restriction in rats.
Lin F; Yu X; Zhang X; Guo Y; Huang Y; Zhou J; Zeng P; Ye D; Huang Y
Placenta; 2013 Oct; 34(10):941-8. PubMed ID: 23910525
[TBL] [Abstract][Full Text] [Related]
17. Lipoxin A4 Activates Nrf2 Pathway and Ameliorates Cell Damage in Cultured Cortical Astrocytes Exposed to Oxygen-Glucose Deprivation/Reperfusion Insults.
Wu L; Li HH; Wu Q; Miao S; Liu ZJ; Wu P; Ye DY
J Mol Neurosci; 2015 Aug; 56(4):848-857. PubMed ID: 25702137
[TBL] [Abstract][Full Text] [Related]
18. Lipoxin A4 restores oxidative stress-induced vascular endothelial cell injury and thrombosis-related factor expression by its receptor-mediated activation of Nrf2-HO-1 axis.
Yang S; Zheng Y; Hou X
Cell Signal; 2019 Aug; 60():146-153. PubMed ID: 31059786
[TBL] [Abstract][Full Text] [Related]
19. Podocytes are new cellular targets of haemoglobin-mediated renal damage.
Rubio-Navarro A; Sanchez-Niño MD; Guerrero-Hue M; García-Caballero C; Gutiérrez E; Yuste C; Sevillano Á; Praga M; Egea J; Román E; Cannata P; Ortega R; Cortegano I; de Andrés B; Gaspar ML; Cadenas S; Ortiz A; Egido J; Moreno JA
J Pathol; 2018 Mar; 244(3):296-310. PubMed ID: 29205354
[TBL] [Abstract][Full Text] [Related]
20. Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF-1α/VEGF via Activating Nrf2 Antioxidant Pathway.
Liu C; Cheng T; Wang Y; Li G; Wang Y; Tian W; Feng L; Zhang S; Xu Y; Gao Y; Li J; Liu J; Cui J; Yan J; Cao L; Pan Z; Qi Z; Yang L
Mol Nutr Food Res; 2024 Feb; 68(4):e2200771. PubMed ID: 38356045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
